Literature DB >> 23716286

A solution to ankle-brachial index limitations in peripheral transluminal angioplasty.

Manuel Pardo1, Miguel Alcaraz, Fernando Luis Bernal, Jose Manuel Felices, Gyingriri Daniel Achel, Francisco Ramon Breijo-Marquez, Manuel Canteras.   

Abstract

PURPOSE: We evaluated the limitations of the ankle-brachial index (ABI) in the revascularisation of diabetic patients with critical limb ischaemia (CLI) who were undergoing peripheral transluminal angioplasty (PTA) compared with the degree of arterial stenosis and with transcutaneous oxygen tension (TcpO2).
MATERIALS AND METHODS: This prospective study assessed 250 consecutive diabetic patients in whom we evaluated results of posterior tibial and dorsalis pedis Doppler, ABI, TcpO2, and duplex scans. In total, 104 patients were considered suitable candidates for PTA.
RESULTS: In 42% of the patients studied, ABI could either not be used (9.34% due to no signal; 14.02% because the artery could not be compressed) or was incorrect (18.7% before PTA; 15.9% after PTA). In contrast, TcpO2 was determined in all cases. After PTA, vessel stenosis decreased from 58.33±20.07% to 21.87±13.57% (p<0.001), whereas ABI increased from 0.79±0.57 to 0.95±0.47 (p<0.001) and TcpO2 from 27.37±10.40 mmHg to 38.23±10.25 mmHg (p<0.001). A statistical analysis revealed scant correlation between techniques (TcpO2 and ABI) (r=0.14).
CONCLUSIONS: ABI shows significant limitations for the diagnosing and treating CLI patients compared with TcpO2.

Entities:  

Mesh:

Year:  2013        PMID: 23716286     DOI: 10.1007/s11547-013-0930-2

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  17 in total

Review 1.  Overview of the diabetic foot.

Authors:  Cameron M Akbari; Robyn Macsata; Bruce M Smith; Anton N Sidawy
Journal:  Semin Vasc Surg       Date:  2003-03       Impact factor: 1.000

2.  Does calculation of ankle brachial pressure index need revision?

Authors:  C Diehm; S Kareem; N Diehm; T Jansen; H Lawall
Journal:  Vasa       Date:  2005-05       Impact factor: 1.961

3.  Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes.

Authors:  C van der Feen; F S Neijens; S D J M Kanters; W P Th M Mali; R P Stolk; J D Banga
Journal:  Diabet Med       Date:  2002-05       Impact factor: 4.359

4.  Increased transcutaneous oxygen pressure is an indicator of revascularization after peripheral transluminal angioplasty.

Authors:  Manuel Pardo; Miguel Alcaraz; Francisco Ramón Breijo; Fernando Luis Bernal; Jose Manuel Felices; Manuel Canteras
Journal:  Acta Radiol       Date:  2010-11       Impact factor: 1.990

5.  Revascularization of a specific angiosome for limb salvage: does the target artery matter?

Authors:  Richard F Neville; Christopher E Attinger; Erwin J Bulan; Ivica Ducic; Michael Thomassen; Anton N Sidawy
Journal:  Ann Vasc Surg       Date:  2009-01-29       Impact factor: 1.466

6.  Pathways to diabetic limb amputation. Basis for prevention.

Authors:  R E Pecoraro; G E Reiber; E M Burgess
Journal:  Diabetes Care       Date:  1990-05       Impact factor: 19.112

7.  Percutaneous transluminal angioplasty for lower-limb critical ischaemia.

Authors:  N J London; K Varty; R D Sayers; M M Thompson; P R Bell; A Bolia
Journal:  Br J Surg       Date:  1995-09       Impact factor: 6.939

8.  Use of interventional procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study.

Authors:  Mohammed Al-Omran; Jack V Tu; K Wayne Johnston; Muhammad M Mamdani; Daryl S Kucey
Journal:  J Vasc Surg       Date:  2003-08       Impact factor: 4.268

9.  ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-03-21       Impact factor: 24.094

Review 10.  Assessment and management of foot disease in patients with diabetes.

Authors:  G M Caputo; P R Cavanagh; J S Ulbrecht; G W Gibbons; A W Karchmer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

View more
  3 in total

1.  Transcutaneous oxygen tension measurements following peripheral transluminal angioplasty procedure has more specificity and sensitivity than ankle brachial index.

Authors:  M Pardo; M Alcaraz; F L Bernal; J M Felices; G D Achel; M Canteras
Journal:  Br J Radiol       Date:  2014-11-28       Impact factor: 3.039

2.  Comparison of perfusion values after percutaneous transluminal angioplasty according to the severity of ischaemia in the diabetic foot.

Authors:  Sik Namgoong; Jong-Phil Yang; Ki-Hyun Yoo; Seung-Kyu Han; Seung-Woon Rha; Ye-Na Lee
Journal:  Int Wound J       Date:  2018-10-12       Impact factor: 3.315

Review 3.  Ozone therapy for diabetic foot.

Authors:  Robert Kushmakov; Jason Gandhi; Omar Seyam; Wendy Jiang; Gunjan Joshi; Noel L Smith; Sardar Ali Khan
Journal:  Med Gas Res       Date:  2018-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.